Massimo Del Fabbro | Translational Research | Breakthrough Research Award

Breakthrough Research Award

Massimo Del Fabbro
Università degli Studi di Milano, Italy
Massimo Del Fabbro
Researcher Massimo Del Fabbro
Affiliation Università degli Studi di Milano
Country Italy
Scopus ID 7004132028
Documents 584
Citations 15791
h-index 66
Subject Area Public Health
Event Health Scientists Awards
ORCID 0000-0001-7144-0984

The advancement of public health and healthcare sciences is strongly connected to the contributions of researchers whose scholarly activities support clinical innovation, evidence-based practice, and interdisciplinary scientific development. Massimo Del Fabbro, affiliated with Università degli Studi di Milano in Italy, has established a substantial academic presence through publications, citations, and collaborative healthcare investigations.[1] This article presents a structured overview of the academic profile, research contributions, and scholarly impact associated with the Breakthrough Research Award under the Health Scientists Awards initiative.[2]

Abstract

This article summarizes the scholarly achievements and academic influence of Massimo Del Fabbro in the field of public health and healthcare sciences. The overview examines publication productivity, citation indicators, institutional affiliations, and interdisciplinary scientific contributions associated with healthcare research and clinical advancement. The article additionally evaluates the relevance of these academic accomplishments within the framework of the Breakthrough Research Award presented by the Health Scientists Awards platform.[1][2]

Keywords

  • Public Health
  • Healthcare Sciences
  • Clinical Research
  • Epidemiology
  • Healthcare Innovation
  • Academic Recognition
  • Università degli Studi di Milano

Introduction

Research in public health and healthcare sciences contributes significantly to the development of clinical methodologies, healthcare management systems, and evidence-based medical practices. Recognition programs within the scientific community often emphasize the importance of sustained publication activity, citation influence, and interdisciplinary collaboration in advancing healthcare knowledge.[2] Massimo Del Fabbro has developed an extensive scholarly profile through contributions to healthcare and public health literature indexed within major academic databases. The researcher’s publication portfolio and citation performance indicate sustained scientific engagement and continued influence within healthcare-related disciplines.[1]

Research Profile

Massimo Del Fabbro is affiliated with Università degli Studi di Milano in Italy and has contributed extensively to scientific investigations related to healthcare sciences and public health. The Scopus author profile associated with Author ID 7004132028 reports 584 indexed documents, reflecting substantial research productivity and long-term academic participation.[1] The academic profile further demonstrates scholarly visibility through 15,791 citations and an h-index of 66. These indicators suggest broad dissemination of research findings and continuing recognition within the international scientific community.[1]

  • Institutional Affiliation: Università degli Studi di Milano
  • Primary Subject Area: Public Health
  • Indexed Publications: 584
  • Citation Count: 15,791
  • h-index: 66

Research Contributions

The scientific contributions associated with Massimo Del Fabbro involve clinical investigations, healthcare evaluation methodologies, epidemiological analysis, and evidence-based healthcare practices. These contributions support the advancement of medical research and provide relevant insights for healthcare professionals and policy-oriented scientific studies.[3] The researcher’s interdisciplinary collaborations and publication activities demonstrate active participation in scientific communication networks and international healthcare research initiatives.[4]

  • Clinical and healthcare research investigations
  • Public health and epidemiological analysis
  • Scientific collaboration in healthcare sciences
  • Evidence-based healthcare methodologies
  • Academic dissemination through indexed journals

Publications

The publication portfolio associated with Massimo Del Fabbro includes numerous articles indexed in internationally recognized academic databases and healthcare journals. The breadth of publications demonstrates consistent scientific activity and participation in interdisciplinary healthcare research initiatives.[1]

  1. Peer-reviewed scientific articles related to healthcare and public health sciences.
  2. Research publications indexed in Scopus and associated healthcare databases.
  3. Collaborative studies addressing healthcare innovation and clinical methodologies.
  4. Evidence-based publications supporting healthcare improvement and scientific advancement.

Research Impact

The citation metrics associated with Massimo Del Fabbro indicate substantial academic visibility and scientific influence within healthcare sciences and public health research. Citation-based indicators are commonly used to evaluate the dissemination and scholarly relevance of scientific publications across academic communities.[1] The combination of publication productivity, interdisciplinary research participation, and citation performance contributes to the researcher’s academic standing and supports continuing engagement in international scientific discourse related to healthcare innovation and evidence-based medicine.[3]

Award Suitability

The Breakthrough Research Award recognizes researchers who demonstrate sustained scientific productivity, interdisciplinary impact, and measurable scholarly influence. Based on publication activity, citation metrics, and healthcare-related research engagement, Massimo Del Fabbro demonstrates several characteristics commonly associated with scientific recognition initiatives.[2] The combination of extensive academic publications, international research visibility, and measurable citation influence supports the relevance of this recognition within the Health Scientists Awards framework and broader scientific community.[1]

Conclusion

Massimo Del Fabbro has contributed significantly to healthcare sciences and public health research through scientific publications, interdisciplinary collaboration, and evidence-based healthcare investigations. The researcher’s publication record, citation performance, and international academic visibility demonstrate continued engagement with scientific advancement and healthcare innovation. This article provides a structured academic overview associated with the Breakthrough Research Award and highlights scholarly contributions within healthcare and public health sciences.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Massimo Del Fabbro, Author ID 7004132028. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7004132028
  2. Health Scientists Awards. (n.d.). Breakthrough Research Award and Health Scientists Awards overview.
    Health Scientists Awards
  3. ORCID. (n.d.). ORCID profile of Massimo Del Fabbro.
    https://orcid.org/0000-0001-7144-0984
  4. Google Scholar. (n.d.). Google Scholar citation profile for Massimo Del Fabbro.
    https://scholar.google.com/citations?user=iaV7iGwAAAAJ&hl=en&oi=ao
  5. Capelli, M., Zuffetti, F., Del Fabbro, M., & Testori, T. Immediate rehabilitation of the completely edentulous jaw with fixed prostheses supported by either upright or tilted implants: a multicenter clinical study.

    https://pubmed.ncbi.nlm.nih.gov/17929526/

Sipping Kemegne Marius Tresor | Pharmacology | Best Researcher Award

Dr. Sipping Kemegne Marius Tresor | Pharmacology | Best Researcher Award

Research scholar | Slovak Academy of Sciences | Slovakia

Dr. Sipping Kemegne Marius Tresor is a biochemist and postdoctoral research fellow whose expertise spans immunopharmacology, cancer biology, inflammatory diseases, and phytomedicine, with a focus on natural bioactive compounds and their translational therapeutic applications. Trained at leading institutions across Africa and Europe, he has developed a strong multidisciplinary foundation integrating molecular biology, pharmacology, biotechnology, and clinical research principles to advance innovation in precision therapeutics. His research has pioneered the exploration and characterization of polysaccharide-rich bioactive fractions from medicinal fungi, particularly Ganoderma species, elucidating their antioxidant, anti-inflammatory, and anti-metastatic potentials and offering promising chemopreventive and therapeutic leads for cancer and immune-mediated disorders. His scientific contributions include peer-reviewed publications in internationally indexed journals and authorship of a scholarly book, demonstrating sustained commitment to advancing biomedical knowledge and global research excellence. Dr. Sipping’s work has been strengthened through impactful collaborations across Africa, Europe, and Asia with prominent scientists and international research groups, fostering interdisciplinary partnerships and capacity building in natural product research and immunotherapeutics. His ongoing investigations focus on isolating novel polysaccharides and developing nanotechnology-enabled drug delivery systems to enhance therapeutic efficacy against chronic inflammatory conditions, such as rheumatoid arthritis, bridging traditional bioresources with cutting-edge biomedical strategies. Beyond laboratory research, he is a certified clinical research professional committed to strengthening translational pathways from preclinical discovery to potential clinical application. His membership in distinguished scientific bodies reflects his dedication to contributing to the global research community. Driven by the vision to harness bioresources and advanced biotechnology for improved public health, Dr. Sipping aims to deliver innovative, accessible, and safe therapeutic options addressing cancer, autoimmune, and infectious diseases, thereby contributing to scientific progress and societal well-being. He has 81 citations from 9 documents with an h-index of 5.

Profiles:  Scopus | ORCID

Featured Publications

1. Sipping, M., Thakur, D., Singh, B., Njamen, D., & Mukherjee, S. (2025). Polysaccharide extract of Ganoderma resinaceum restricts breast cancer progression in vitro by intervening in epithelial–mesenchymal transition and cancer stemness. Revista Brasileira de Farmacognosia.

2. Sipping, M., Sathish Kumar, T., & Kamdem, N. (2025). Scientific investigation on antibacterial, antioxidant, cytotoxic effects and TLC bioautography of Terminalia schimperiania stem bark extracts. Journal of Complementary and Integrative Medicine.

3. Kamga Silihe, K., Defo Mbou, W., Ngo Pambe, J. C., Kenmogne, L. V., Fotso Maptouom, L., Kemegne Sipping, M. T., Zingue, S., & Njamen, D. (2023). Comparative anticancer effects of Annona muricata Linn (Annonaceae) leaves and fruits on DMBA-induced breast cancer in female rats. BMC Complementary Medicine and Therapies.

4. Nana Tchoupang, E., Yadji, V., Wangbara, J. B., Kemegne Sipping, M. T., Zingue, S., Njamen, D., & Mutalik, S. (2022). In vitro and in vivo antiproliferative actions of Solanum gilo Raddi (Solanaceae) fruit extract on breast tissues. Advances in Pharmacological and Pharmaceutical Sciences.

5. Kamga Silihe, K., Zingue, S., Kemegne Sipping, M. T., Busuioc Cazanevscaia, A., Dediu Botezatu, A. V., Njamen, D., & Dinica, R. M. (2022). The antioxidant potential of Ficus umbellata Vahl (Moraceae) that accelerates in vitro and in vivo anti-inflammatory protective effects. Applied Sciences.